- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00312247
Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
18. maj 2015 opdateret af: Michael D. Sussman, MD, Shriners Hospitals for Children
The purpose of this research study is to understand the walking patterns, strength and function changes of boys with Duchenne muscular dystrophy on/off corticosteroids to determine the best timing and treatment options to maintain walking for as long as possible.
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease of muscle characterized by a progressive loss of functional muscle mass, which is replaced with fibrofatty tissue.
Historically, boys with DMD lose the ability to walk between the ages of 8-12 years, due to progressive weakness of the quadriceps coupled with the development of contractures at the hip, knee and ankle.
This progressive loss in function necessitates individuals with DMD to spend less time walking and more time in wheelchairs, leading to the development of spinal deformities.
Recently, corticosteroids have been shown to reduce the expected loss of muscle strength, extend the time that ambulation and standing are maintained, and minimize or eliminate spinal deformity in individuals with DMD; yet, the side effects of such treatment preclude use in some patients.
To date, differences in gait patterns and other markers of disease progression between boys on corticosteroids and those not utilizing such treatment have not been objectively quantified.
This lack of knowledge is a major obstacle to determining the most effective treatment for subsets of boys with DMD.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
85
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90095
- UCLA Department of Orthopaedic Surgery
-
Sacramento, California, Forenede Stater, 95817
- Shriners Hospitals for Children
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97239
- Shriners Hospitals for Children
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
4 år til 21 år (Barn, Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Han
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Boys with DMD who are ambulatory starting at the age of 4 until ambulation ceases
Beskrivelse
Inclusion Criteria:
- Confirmed diagnosis of DMD
- Male.
- Four years of age or older.
- Ability to walk independently for five minutes to 10 minutes at self-selected speed.
- Ability to cognitively understand directions for testing procedures.
Exclusion Criteria:
- Female
- Nonambulatory
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
Boys taking steroids
Boys who are taking prednisone or deflazacort
|
|
Boys who are steroid naive
Boys who are not taking steroids for a variety of reasons
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Gait pattern
Tidsramme: every six months (2x/year)
|
computerized assessment of walking
|
every six months (2x/year)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
muscle strength
Tidsramme: every six months (2x/year)
|
quantitative assessment of strength with a Biodex
|
every six months (2x/year)
|
|
energy cost of walking
Tidsramme: every six months (2x/year)
|
assessment of how much energy it takes to walk, assessed with a Cosmed K4b2
|
every six months (2x/year)
|
|
gross motor functional skills
Tidsramme: every six months (2x/year)
|
assessment of gross motor skills, ie getting up off the floor, ascending/descending stairs
|
every six months (2x/year)
|
|
Step activity Monitor-participation
Tidsramme: one week every six months
|
measurement of the number of steps taken in the community/home environment during weekdays and weekends
|
one week every six months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Michael D Sussman, MD, Shriners Hospitals for Children
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Sienko Thomas S, Buckon CE, Nicorici A, Bagley A, McDonald CM, Sussman MD. Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol. 2010 Sep;25(9):1103-9. doi: 10.1177/0883073810371002. Epub 2010 Jun 29.
- McDonald CM, McDonald DA, Bagley A, Sienko Thomas S, Buckon CE, Henricson E, Nicorici A, Sussman MD. Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy. J Child Neurol. 2010 Sep;25(9):1130-44. doi: 10.1177/0883073810371509. Epub 2010 Jun 17.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. april 2006
Primær færdiggørelse (Faktiske)
1. december 2014
Studieafslutning (Faktiske)
1. marts 2015
Datoer for studieregistrering
Først indsendt
5. april 2006
Først indsendt, der opfyldte QC-kriterier
5. april 2006
Først opslået (Skøn)
7. april 2006
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
19. maj 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. maj 2015
Sidst verificeret
1. maj 2015
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SHC-DMD-79115
- SHC-79115 (Andet bevillings-/finansieringsnummer: Shriners Hospitals for Children)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Duchennes muskeldystrofi
-
National Institute of Allergy and Infectious Diseases...RekrutteringAutoimmun Polyendocrinopathy Candidiasis ectodermal dystrophy enteritisForenede Stater
-
Opus Genetics, IncRetina Foundation of the SouthwestRekrutteringARB | Bedste Vitelliform Macula Dystrophy | Bvmd | Autosomal-dominerende bestrophinopatiForenede Stater
-
Columbia UniversityNational Eye Institute (NEI); Centre Hospitalier National d'Ophtalmologie... og andre samarbejdspartnereRekrutteringRetinitis Pigmentosa | Bedste Vitelliform Macula DystrophyForenede Stater, Tyskland, Frankrig
-
Stealth BioTherapeutics Inc.AfsluttetFuchs' Corneal Endothelial Dystrophy (FCED)Forenede Stater
-
Vienna Institute for Research in Ocular SurgeryRekrutteringKort Dot Fingerprint DystrophyØstrig
-
PYC TherapeuticsAktiv, ikke rekrutterendeRetinitis Pigmentosa | Øjensygdomme, arvelig | Nethindedystrofier | Nethindedystrofistang | Retinal Dystrophy Rod ProgressiveForenede Stater, Australien
-
Mayo ClinicNational Eye Institute (NEI)AfsluttetNethindesygdom | Bedste Vitelliform Macula Dystrophy | Bestrofinopati | Vitelliform makuladystrofi hos voksne | Autosomal Dominant VitreoretinalchoroidopatiForenede Stater
-
Stichting Achmea Slachtoffer en SamenlevingAfsluttetRSD (Reflex Sympathetic Dystrophy) | Algodystrofi | CRPS Type IHolland
-
Vienna Institute for Research in Ocular SurgeryIkke rekrutterer endnuFuchs endoteldystrofi | Kort Dot Fingerprint Dystrophy | Post-penetrering af keratoplastik | Post-Descemet Membrane Endothelial Keratoplasty | Sunde hornhinder | OST-DESCEMET Stripping Automated Endothelial KeratoplastyØstrig
-
Healeon Medical IncTrukket tilbageFibromyalgi | RSD (Reflex Sympathetic Dystrophy) | CRPS - komplekst regionalt smertesyndrom type IForenede Stater, Honduras